[Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases]. [PDF]
Pan SA, Shi J.
europepmc +1 more source
[A Case Report of Successful Control of Refractory Tumor Fever in Lung Adenocarcinoma with Interleukin-6 Antibody Tocilizumab]. [PDF]
Li Y, Li C, Li B.
europepmc +1 more source
光动力治疗因其具有高的时空选择性和低的系统损伤,成为一种新兴的治疗肿瘤的方法。光动力治疗中的光敏剂药物大部分水溶性差,因而构建合适的光敏剂递送体系成为光动力治疗的关键。传统的光敏剂递送体系普遍存在载药量低,组分不明确等弊端。为解决上述问题,我们提出了以结构明确、生物相容性良好的寡肽分子调控光敏剂分子自组装,发展新型的药物递送体系(Fig.1)。通过两亲性的二肽(如苯丙氨酸二肽)或者改性氨基酸(如芴甲氧羰基-L-赖氨酸(Fmoc-L-lys))调控与光敏剂分子(二氢卟吩e6(Ce6 ...
闫学海 +3 more
core
[Role of Trained Immunity in the Association Between Periodontitis and Rheumatoid Arthritis]. [PDF]
You R, Cui Y, Sun J.
europepmc +1 more source
[Research progress of natural collagen peptides and its skincare efficacy]. [PDF]
Wu Y, Ju H, Lyu Y.
europepmc +1 more source
解淀粉芽孢杆菌能够在其自身生长过程中通过非核糖体途径合成多种类型的抗菌脂肽。并且这些脂肽类化合物在其生物合成过程中会受到不同内外因子的调控。本文首先通过PCR、HPLC-MS和MS/MS技术相结合的方法对解淀粉芽孢杆菌Q-426所分泌抗菌物质的结构进行了鉴定:C-14、C-15、C-16 bacillomycin D(属于iturin家族),C-15、C-16、C-17 fengycin A 和C-17 fengycin B。其次 ...
赵朋超
core
[Acquired factor ⅩⅢ deficiency with FⅩⅢ inhibitor secondary to rheumatoid arthritis: a case report]. [PDF]
Zhu BC, Cai HC, Zhang Y, Wang L, Wang W.
europepmc +1 more source
文中选用新型超大孔聚甲基丙烯酸缩水甘油酯微球偶联木瓜蛋白酶,用于催化酵母蛋白水解制备抗氧化肽。木瓜蛋白酶在微球上负载量为66.5 mg/g,并且均匀分布于微球内外表面;固定化酶比活力为137.5 U/mg,活力回收率达60.6%,高于商品化介孔微球固定化酶的活力。在固定化木瓜蛋白酶的可控催化作用下,酵母蛋白水解产物的最高抗氧化活力为81.2 mol TE/g,远高于蔬果的抗氧化活力。此外,固定化木瓜蛋白酶重复使用20次后仍剩余35 ...
刁文锦 +6 more
core
[POEMS syndrome misdiagnosed as systemic sclerosis: A case report]. [PDF]
Liang J, Zhang X, Yao H.
europepmc +1 more source
[Recent Research Progress and Prospects on Periodontitis Affecting Systemic Comorbidities via the Oral-Gut Axis]. [PDF]
Zhang S, Li Y, Yang Z, Huang H, Pan Y.
europepmc +1 more source

